Description
Oxy Peptide PT-141 5 mg + Gonadorelin 1 mg is a premium dual-peptide research formulation combining PT-141 (Bremelanotide) with Gonadorelin, two extensively studied peptides recognized for their distinct roles in neuroendocrine and reproductive hormone research. This advanced peptide blend provides researchers with a valuable platform for investigating melanocortin receptor activity, hypothalamic-pituitary-gonadal (HPG) axis function, gonadotropin-releasing hormone (GnRH) signaling, and peptide-mediated endocrine communication.
Presented in a lyophilized 6 mg vial, this high-purity research formulation is manufactured to deliver exceptional stability, consistency, and reliability for advanced laboratory applications. Oxy Peptide PT-141 + Gonadorelin enables scientists to explore peptide synergy, receptor biology, neuroendocrine regulation, and hormonal signaling pathways in controlled scientific environments.
Manufactured under stringent quality standards, Oxy Peptide PT-141 + Gonadorelin is intended exclusively for laboratory and scientific research, delivering the precision and purity expected by professionals engaged in modern peptide science.
Key Features
- Advanced dual-peptide research blend
- Combines PT-141 (Bremelanotide) and Gonadorelin
- Total peptide content: 6 mg per vial
- 1 lyophilized vial per pack
- High-purity research-grade formulation
- Commonly studied in neuroendocrine and reproductive hormone research
- Suitable for investigations involving melanocortin receptor activity, GnRH signaling, and endocrine physiology
- Manufactured under strict quality standards
- Intended exclusively for laboratory and scientific research applications
Contents
Active Ingredients:
- PT-141 (Bremelanotide) – 5 mg
- Gonadorelin – 1 mg
Packaging: 1 Lyophilized Vial
Reviews
There are no reviews yet.